GCG and obesity due to melanocortin 4 receptor deficiency: Glucagon-like peptide-1 analogues (GLP-1As) are now well-established and widely used agents for the treatment of obesity, and they have demonstrated superior efficacy compared to insulin and metformin in the management of T2DM.